Skip to main content
Fig. 1 | Lipids in Health and Disease

Fig. 1

From: Effect of sacubitril/valsartan on lipid metabolism in patients with chronic kidney disease combined with chronic heart failure: a retrospective study

Fig. 1

Changes of triglyceride (TG) in patients treated with sacubitril/valsartan(blue) or valsartan(red) after 16 weeks of treatment. The first and third quartiles are represented by the box’s lower and upper limits, respectively, and the minimum and maximum values are represented by the lower and upper whiskers of the box. Abbreviations: ΔTG = pre-treatment minus post-treatment. P, the probability values of differences between the two groups

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X